Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 329

1.

[Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma].

Chang XJ, Wang CP, Qu JH, Lu YY, Chen Y, Bai WL, Gao XD, Hao LY, Xu GL, Wang H, Yang YP.

Zhonghua Zhong Liu Za Zhi. 2012 Oct;34(10):748-52. doi: 10.3760/cma.j.issn.0253-3766.2012.10.007. Chinese.

PMID:
23291068
2.

High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma.

Yang YP, Qu JH, Chang XJ, Lu YY, Bai WL, Dong Z, Wang H, An LJ, Xu ZX, Wang CP, Zeng Z, Hu KQ.

J Transl Med. 2013 Feb 15;11:41. doi: 10.1186/1479-5876-11-41.

3.

Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma.

Qu JH, Chang XJ, Lu YY, Bai WL, Chen Y, Zhou L, Zeng Z, Wang CP, An LJ, Hao LY, Xu GL, Gao XD, Lou M, Lv JY, Yang YP.

World J Gastroenterol. 2012 Jun 21;18(23):2995-3003. doi: 10.3748/wjg.v18.i23.2995.

4.

MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.

Xie C, Wu J, Yun J, Lai J, Yuan Y, Gao Z, Li M, Li J, Song L.

PLoS One. 2013 May 23;8(5):e64235. doi: 10.1371/journal.pone.0064235. Print 2013.

5.

Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma.

Qiu J, Huang P, Liu Q, Hong J, Li B, Lu C, Wang L, Wang J, Yuan Y.

J Transl Med. 2011 Sep 29;9:166. doi: 10.1186/1479-5876-9-166.

6.

[CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].

Wang ZS, Wu LQ, Yi X, Geng C, Li YJ, Yao RY, Hu WY, Han B.

Zhonghua Zhong Liu Za Zhi. 2012 Oct;34(10):753-8. doi: 10.3760/cma.j.issn.0253-3766.2012.10.008. Chinese.

PMID:
23291069
7.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
8.
9.

[Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].

Gu DH, Zhu YZ, Wang X, Bai ZC, Ping JL, Chen Q, Zhu R.

Zhonghua Zhong Liu Za Zhi. 2013 Apr;35(4):282-7. doi: 10.3760/cma.j.issn.0253-3766.2013.04.009. Chinese.

PMID:
23985257
10.

Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma.

Mayinuer A, Yasen M, Mogushi K, Obulhasim G, Xieraili M, Aihara A, Tanaka S, Mizushima H, Tanaka H, Arii S.

Ann Surg Oncol. 2013 Jan;20(1):305-17. doi: 10.1245/s10434-012-2395-2. Epub 2012 Oct 13.

11.

[The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].

Liu Y, Chen X, Peng S, Fang H, Wu Y, Peng C, Shi L, Bai M, Xu B, Wang J, Deng G.

Zhonghua Yi Xue Za Zhi. 2002 Nov 25;82(22):1553-6. Chinese.

PMID:
12609066
12.

Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9.

Gao J, Ding F, Liu Q, Yao Y.

Mol Cell Biochem. 2013 Apr;376(1-2):21-32. doi: 10.1007/s11010-012-1545-y. Epub 2012 Dec 12.

PMID:
23232575
13.

MACC1 expression correlates with PFKFB2 and survival in hepatocellular carcinoma.

Ji D, Lu ZT, Li YQ, Liang ZY, Zhang PF, Li C, Zhang JL, Zheng X, Yao YM.

Asian Pac J Cancer Prev. 2014;15(2):999-1003.

14.

Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.

Yu MC, Lee YS, Lin SE, Wu HY, Chen TC, Lee WC, Chen MF, Tsai CN.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S455-63. doi: 10.1245/s10434-011-1946-2. Epub 2011 Aug 6.

PMID:
21822558
15.

[Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma].

Zhao YN, Cao J, Wu FX, Ou C, Yuan WP, Mo QG, Wei W, Li Y, Su JJ, Liang AM.

Ai Zheng. 2004 Jul;23(7):762-6. Chinese.

PMID:
15248908
16.

[OCT4 expression in hepatocellular carcinoma and its clinical significance].

Huang PZ, Lu CL, Li BK, Hong J, Huang L, Wang L, Zhang Y, Yuan YF.

Chin J Cancer. 2010 Jan;29(1):111-16. Chinese.

17.

L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.

Guo X, Xiong L, Zou L, Sun T, Zhang J, Li H, Peng R, Zhao J.

Diagn Pathol. 2012 Aug 13;7:96. doi: 10.1186/1746-1596-7-96.

18.

[Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].

Moon JI, Kim JM, Jung GO, Chun JM, Choi GS, Park JB, Kwon CH, Kim SJ, Jo JW.

Korean J Hepatol. 2008 Jun;14(2):185-96. doi: 10.3350/kjhep.2008.14.2.185. Korean.

19.

Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.

Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.

J Clin Gastroenterol. 2009 May-Jun;43(5):482-8. doi: 10.1097/MCG.0b013e318182015a.

PMID:
19197197
20.

Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.

Zha TZ, Hu BS, Yu HF, Tan YF, Zhang Y, Zhang K.

Tumour Biol. 2012 Dec;33(6):2125-34. doi: 10.1007/s13277-012-0472-6. Epub 2012 Aug 4.

PMID:
22864671
Items per page

Supplemental Content

Write to the Help Desk